budesonide - The Covid Index

Related Index Entries

Antiviral Effect of Budesonide against SARS-CoV-2
Budesonide Works
Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
ProLung™-budesonide Inhibits SARS-CoV-2 Replication and Reduces Lung Inflammation

Topic ID

1030